Virtual Library
Start Your Search
Y. Liu
Author of
-
+
Best abstracts selected from submissions 4 (ID 4)
- Event: ACLC 2018
- Type: Oral Session
- Track:
- Presentations: 1
- Moderators:
- Coordinates: 11/09/2018, 10:50 - 11:30, Crystal Ballroom
-
+
OA08 - Efficacy and Safety of Sintilimab Combined with 1st Line Chemotherapy in Advanced Squamous Cell Non-small Cell Lung Cancer (ID 99)
10:50 - 11:30 | Author(s): Y. Liu
- Abstract
Background:
Sintilimab, a novel full-humanized IgG4 anti-PD-1 monoclonal antibody, showed its potent anti-tumor efficacy in preclinical models. Hence, we evaluated the efficacy and safety of sintilimab in combination with gemcitabine and cisplatin in treatment na